Friday 6 November 2026 Export AZN’s income statement to Excel — free account

AstraZeneca PLC

AZN Healthcare Drug Manufacturers General

AstraZeneca PLC’s revenue for fiscal 2025 (year ended December 2025) was $58.7 billion, up 8.63% from fiscal 2024.

Revenue: +6.70%
EPS: +22.5%
Free cash flow: +1.99%
Total debt: +1.75%

Quarter to September 2026, against a year earlier

187.20 1.81 −0.96%

Follow AZN

Alert me

Market cap: $289.8B
P/E: 26.3×
Fwd P/E: 24.5×
Dividend yield: 1.71%
F-score: 9/9
Altman Z: 3.52
Beneish M: −2.51
Dividend safety: 54/100

Overview

AstraZeneca PLC (AZN) P/B ratio

Alert me on P/B ratio

As of 5 November 2026, AstraZeneca PLC (AZN) trades at a P/B ratio of 5.6×. Over the past ten years it has ranged from 3.8× (March 2016) to 12.0× (May 2020); the current reading is higher than 47% of that period. That is above the Drug Manufacturers General industry median of 5.2× and above the Healthcare sector median of 2.3×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/AZN/pb-ratio" width="100%" height="360" style="border:0" loading="lazy" title="AstraZeneca PLC P/B ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/AZN/metrics/pb-ratio">AstraZeneca PLC (AZN) P/B ratio — stockrow.com</a></p>

Period	P/B ratio	Change
FY2025	5.6×	13.11%
FY2024	4.9×	(6.08%)
FY2023	5.3×	(7.84%)
FY2022	5.7×	36.30%
FY2021	4.2×	(50.65%)
FY2020	8.5×	(5.87%)
FY2019	9.0×	31.37%
FY2018	6.9×	31.34%
FY2017	5.2×	24.06%
FY2016	4.2×	(9.30%)

Period	P/B ratio	Change
Sep 2026	4.8×	(17.22%)
Jun 2026	5.8×	(9.44%)
Mar 2026	6.4×	15.54%
Dec 2025	5.6×	10.63%
43 more quarters	Free account

Against its own ten years

Low 3.8× High 12.0×

Ten-year median 5.7×

Current reading's percentile 45

Company	P/B ratio
ABBV AbbVie Inc. compare	n/m
PFE Pfizer Inc. compare	1.9×
NVO Novo Nordisk A/S compare	5.2×
BMY Bristol Myers Squibb Company compare	5.5×
AZN AstraZeneca PLC	5.6×
NVS Novartis AG compare	8.2×
MRK Merck & Co., Inc. compare	8.6×
GILD Gilead Sciences, Inc. compare	16.1×
AMGN Amgen Inc. compare	21.4×
Drug Manufacturers General industry median	5.2×
Healthcare sector median	2.3×
Market median	1.7×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

AstraZeneca PLC (AZN) P/B ratio

P/B ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/B ratio against peers

What P/B ratio is

More on AZN

P/B ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/B ratio against peers

What P/B ratio is

More on AZN

Stockrow Weekly